FDA and global regulatory affairs, consumer health, and professional development


Expert guidance for industry professionals and clear, reliable information for patients and consumers

Medical Devices
Pharma square image
Biologics Square Image
Combination Products
In Vitro Diagnostics square

Abbott/Thoratec Recalls HeartMate II and HeartMate 3 LVAS

Recall Alert: HeartMate II and HeartMate 3 Left Ventricular Assist Systems (LVAS)  The FDA has issued a Class I recall, the most serious type, for the HeartMate II and HeartMate 3 Left Ventricular Assist Systems (LVAS) due to potential serious injuries or death...

Fresenius Kabi Recalls Ivenix Infusion Pump Software 

Urgent Class I Recall Notice   A crucial recall notice has been issued by Fresenius Kabi USA, LLC for the LVP Software of the Ivenix Infusion System (IIS), Version 5.8.0, distributed between March 6, 2023, and March 20, 2024. The recall, initiated on March 7, 2024, is...

Urgent Recall for Boston Scientific Obsidio Conformable Embolic 

Urgent Class I Recall Notice   Boston Scientific Corporation issued a critical recall notice on February 20, 2024, for its Obsidio Conformable Embolic products. The recall affects products distributed between May 8, 2023, and February 8, 2024.   Product Details  ...

Medos International Recalls CEREBASE DA Guide Sheath 

Urgent Class I Recall Notice   Medos International Sàrl has issued an urgent recall for the Cerenovus CEREBASE DA Guide Sheath, a neurovascular catheter commonly used in procedures requiring precise navigation and access to blood vessels in the brain. The recall was...

FDA Alert: Baxter Recalls Spectrum Infusion Pumps

Baxter Spectrum Infusion Pump Alert Date: July 2025Device: Sigma Spectrum Infusion System (V6 and V8 Platforms)Manufacturer: Baxter HealthcareIssue Type: Urgent Medical Device RecallFDA Status: High-risk; active monitoring in progress The FDA has issued an early alert...

How Unsafe Medical Devices Can Slip Through the Cracks

Healthcare professionals and the device industry share responsibility for timely adverse event reportingGlobal device market withdrawals not always followed in US In a world of global trade and instant communication, you might assume that a medical device deemed...

Study Reveals Delays in Medical Device Adverse Event Reporting

Healthcare professionals and the device industry share responsibility for timely adverse event reportingLapses defeat the purpose of adverse event reporting A recent study published in the British Medical Journal has spotlighted a troubling trend: many medical device...

QSR-to-QMSR Paper Gap Audit

Is Your Quality Management System Ready for QMSR? As FDA’s transition from the QSR to the QMSR approaches, many medical device manufacturers are discovering that “substantially equivalent” doesn’t mean “completely aligned.” Even companies with solid QSR documentation...

FDA Grants Accelerated Approval to Tarlatamab-dlle

Treatment for lung cancer with progression following platinum-based chemotherapy  On May 16, 2024, the Food and Drug Administration (FDA) granted accelerated approval to Imdelltra (tarlatamab-dlle) manufactured by Amgen, Inc. for the treatment of extensive stage small...

FDA Approves New Imaging Drug Lumisight  

A Significant Improvement for Surgical Oncology  The U.S. Food and Drug Administration (FDA) has granted approval to LumiSight (pegulicianine) for use in adults undergoing breast lumpectomy, marking a significant advancement in surgical oncology.   Lumisight, a...

FDA Issues Warning on Counterfeit Botox Products 

Real Botox PackagingReal Botox Cosmetic PackagingReal Botox PackagingCounterfeit Botox Products  The U.S. Food and Drug Administration (FDA) has issued a critical alert concerning the presence of counterfeit Botox products in various states, posing severe risks to...

FDA Approves Xolremdi for WHIM Syndrome 

A Breakthrough for Rare Infections  In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has granted approval for Xolremdi (mavorixafor) capsules, marking a significant milestone in the treatment of WHIM syndrome. Let's delve into what this...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Generic Eliquis

Generic Eliquis Editor's note: FDA originally announced the approval of generic equivalents to Eliquis in 2019, and updated that information the next year. We are publishing this information as a response to reader requests for more information about generic Eliquis....

FDA Approves New Imaging Drug Lumisight  

A Significant Improvement for Surgical Oncology  The U.S. Food and Drug Administration (FDA) has granted approval to LumiSight (pegulicianine) for use in adults undergoing breast lumpectomy, marking a significant advancement in surgical oncology.   Lumisight, a...

FDA Issues Warning on Counterfeit Botox Products 

Real Botox PackagingReal Botox Cosmetic PackagingReal Botox PackagingCounterfeit Botox Products  The U.S. Food and Drug Administration (FDA) has issued a critical alert concerning the presence of counterfeit Botox products in various states, posing severe risks to...

FDA Approves XACT Carotid Stent System

A Breakthrough for Stroke Prevention  Abbott Vascular Inc. has received FDA approval for its groundbreaking XACT Carotid Stent System, a significant advancement in stroke prevention technology. Approved on February 7, 2024, this innovative system offers new hope for...

Global Medical Device Regulation
Global Regulatory
Regulatory Information Management Systems
RIMS Architecture tile square
RIMS for Small and Emerging Businesses
RIMS Readiness Self-Assessment
QMSR Inspections tile
QMSR Implementation Strategies tile
QMSR Terms and Definitions Tile
Affected QMSR regulations and standards tile
QMSR for small manufacturers tile
Medical Device Recalls
Medical Device Warning Letters 1
Pharma Recalls
Pharma Warning Letters
Global Regulatory
Pharma Innovation

Welcome to Medical Devices and Pharma, a website dedicated to providing timely and relevant medical device and pharma information to the regulated medical device and pharmaceutical industries, and consumers of those products.

Our goal is to provide organized, clearly written information from regulatory affairs and consumer perspectives.

  • Key information from the Food and Drug Administration (FDA), the federal regulatory agency responsible for providing oversight over the industries and assuring the safety and efficacy of their products.
  • Regulatory services for compliance, market access, and crisis management
  • Information about innovation, including new products cleared for use in the U.S. market.
  • News stories with topics ranging from product issues to market trends.

Perhaps most importantly, we will strive to maintain vigilance over product issues and their impacts. Check back here for consumer news, product alerts, and current litigation.

Artificial Intelligence

Discover how Artificial Intelligence is revolutionizing the medical device and pharmaceutical industries.

Stay up-to-date with the latest advancements and breakthroughs that are shaping the future of healthcare.

QMSR - Quality Management System Regulation

The U.S. Food and Drug Administration (FDA) has introduced significant updates to its regulatory framework for medical device manufacturers with the transition from the Quality System Regulation (QSR) to the Quality Management System Regulation (QMSR).

This modernization aligns with global standards, streamlining compliance for manufacturers who market devices internationally while maintaining a strong focus on patient safety and product quality.

Quality Management System Regulation - QMSR

Regulatory Information Management Systems - RIMS

Medical Devices
Pharma square image
Combination Products

A veteran-owned business
located in
Iowa’s Cedar Valley